COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF

PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

SUBSTITUTED 1',2'-DIHYDRO-3'H-SPIRO[CYCLOHEXANE-1,4'-PYRIMIDO[5',4':4,5]PYRROLO[2,1-c][1,2,4]TRIAZIN]-3'-ONES AS CYCLIN-DEPENDENT KINASE INHIBITORS

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

AZASPIRO WRN INHIBITORS

CRYSTALLINE FORMS OF TRILACICLIB AND TRILACICLIB SALTS

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

Heterocyclic Compounds and Methods of Use

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

COMPOSITIONS OF FOLATE ABSORPTION INHIBITORS AND METHODS THEREOF

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

DISPIROPYRROLIDINE DERIVATIVES

ANTI-VIRAL COMPOUNDS

MAP4K1 INHIBITORS

Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitors

SELECTIVE CDK 4/6 INHIBITOR CANCER THERAPEUTICS

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors

CDK INHIBITORS

SOLID STATE FORMS OF TRILACICLIB AND OF TRILACICLIB SALTS

TETRAHYDRO-SPIROINDOLINE-PYRROLOPYRROLE-TRIONES INHIBITORS OF THE NRF2-BETA-TRCP INTERACTION FOR USE IN THE TREATMENT OF FATTY LIVER DISEASE

Selective CDK4/6 inhibitor cancer therapeutics

BENZIMIDAZOLE DERIVATIVES

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

UNNATURAL AMINO ACIDS AND USES THEREOF

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof

Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitors

DISPIROPYRROLIDINE DERIVATIVES

SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF

CDK INHIBITORS

Morphic forms of trilaciclib and methods of manufacture thereof

ERK inhibitor and use thereof

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS

MDM2 inhibitors

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION

Hepatitis B antiviral agents

1,2,3',5'-TETRAHYDRO-2'H-SPIRO[INDOLE-3,1'-PYRROLO[3,4-C]PYRROLE]-2,3'-DIONE COMPOUNDS AS THERAPEUTIC AGENTS ACTIVATING TP53

MTOR inhibitor compounds

CDK inhibitors

Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof

Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

Spiroindolinones and therapeutic uses thereof

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION

Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

CDK inhibitors

Metal halide crystals having a nanotube structure and methods

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION

NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS

Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

CDK inhibitors

CDK inhibitors

CDK inhibitors

Lactam kinase inhibitors

Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors

Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal cellular proliferation

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors

Compounds and methods for the treatment of cystic fibrosis

Organic electroluminescent materials and devices

Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors

Pentaarylbiimidazole compound and production method for said compound

COMPOUNDS COMPRISING 1,1a,2,5a-TETRAHYDROSPIRO[INDOLE-3,2a-PYRROLE]-2,5a-DIONE SYSTEM AS INHIBITORS P53-MDM2 PROTEIN-PROTEIN INTERACTION

Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

Lactam kinase inhibitors

CDK inhibitors

Substituted polycyclic carbamolypyridone derivative

Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors

SPIROCYCLIC COMPOUNDS CONTAINING SPIRO[INDOLYL-3,1'-PYRROLO[3,4-C]PYRROLE] CORE AND SULPHUR-CONTAINING AMINO ACID RESIDUES

Chemical compounds

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIBITORS

Lactam kinase inhibitors

TRICYCLIC GUANIDINE DERIVATIVE

Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors

Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

CDK inhibitors

CDK inhibitors

Chemical compounds

Materials for organic electroluminescent devices

Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation

7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions

DISPIROPYRROLIDINE DERIVATIVES

Process for producing optically active succinimide derivatives and intermediates thereof

CDK inhibitors

CDK inhibitors

CDK inhibitors

Process for producing optically active succinimide derivatives

Dispiropyrrolidine derivatives

Heterocyclic compounds containing an indole core

Photochromic material

7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof

Materials for organic electroluminescent devices

DISPIROPYRROLIDINE DERIVATIVES

Substituted polycyclic carbamoylpyridone derivative

Gamma secretase modulators

Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones

Process for producing optically active succinimide derivatives and intermediates thereof

7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Organic compounds

Process for production of 2,5 dioxopyrrolidine 3 carboxylate

Acylation of hindered amines and functionalized bis-peptides obtained thereby

Chemical compounds

Cell adhesion promoting agent and method of promoting cell adhesion

N-ARYL DIAZASPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF

Modulators of muscarinic receptors

Organic compounds

N-aryl diazaspirocyclic compounds and methods of preparation and use thereof

Modulators of muscarinic receptors

HCV PROTEASE INHIBITORS

N-aryl diazaspiracyclic compounds and methods of preparation and use thereof

Detection and identification of saxiphilins using saxitoxin-biotin conjugates

N-aryl diazaspiracyclic compounds and methods of preparation and use thereof

Antihistaminic spiro compounds

Macrocyclic spiropyrrolidine derived antiviral agents

Organic compound with tetrahedral-like geometry